The Release of Platelet-Activating Factor during Phagocytosis by Polymorphonuclear Neutrophils and Monocytes
Platelet-activating factor (PAF) is a soluble factor that induces platelet aggregation and release reaction (1–4), independently from ADP- and Arachidonic Acid/Thromboxane A2 -mediated pathways (2, 4). PAF is alow molecular weight phospholipid (1-0-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine)(5,6). PAF was initially obtained from antigen-stimulated, IgE-sensitized rabbit basophils (2). In man PAF release from basophils still awaits confirmatory evidence, mainly because in man basophils constitute a much smaller fraction of the total leukocytes than in the rabbit. Lewis recovered a PAF-like activity from purified leukemic basophils in the presence of Calcium Ionophore (7). Later, we have shown that immune complexes (IC), the specific antigen, anaphylatoxin and neutrophil cationic proteins stimulate PAF release from human leukocytes (8). Although basophil degranulation was coincident with PAF release, the cell populations used in those experiments were relatively impure. More recently, ultrastructural evidence of platelet interaction only with degranulated basophils but not with either neutrophils or monocytes was obtained when basophils were degranulated by the specific antigen, anti-IgE or Synachten (9). However, PAF release occurred independently from basophil degranulation during phagocytosis by polymorphonuclear neutrophils (PMN) and monocytes (9,10). Lotner et al. demonstrated that purified human PMN are capable of releasing PAF (11). The purpose of the present report was to comparatively study the mechanism of PAF release from PMN and monocytes under phagocytic stimuli.
KeywordsChloroform Nitrite Histamine Prostaglandin Choline
Unable to display preview. Download preview PDF.
- 5).J. BENVENISTE, M. TENCE, J. BIDAULT, C. BOULLET and J. POLONSKY: Sémi-synthèse et structure proposée du facteur activant les plaquettes (PAF): PAF-acether, un alkyl ether analogue de le lysophosphatidylcholine. C.R.Acad.Sci. (Paris), 289: 1037 (1979).Google Scholar
- 9).G. CAMUSSI, M. AGLIETTA, R. CODA, F. BUSSOLINO, W. PIACIBELLO and C. TETTA: Release of platelet activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology (1980) in press.Google Scholar
- 10).G. CAMUSSI, F. BUSSOLINO, C. TETTA, J. BENVENISTE and A. VERCELLONE: Platelet-activating factor and glomerulonephritis. In Hemostasis, Prostaglandins and Renal Disease’) Eds. G.Remuzzi et al., Raven Press New York, 133, 1980.Google Scholar
- 12).G. CAMUSSI, C. TETTA, F. BUSSOLINO, F.C. CAPPIO, R. CODA, C. MASERA and G. SEGOLONI: Mediators of immune complex-induced aggregation of polymorph.onuclear neutrophils. I.C5a Anaphylatoxin, Neutro-phil Cationic Proteins and Their Cleavage Fragments. Int.Archs Allergy appl.Immun. 62: 1–15 (1980).CrossRefGoogle Scholar
- 19).R.M. PINCKARD, R.S. FARR and D.S. HANAHAN: Physicochemical and fun ctional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE-sensitized basophils. J.Imuunol. 123, 1847 (1979).Google Scholar
- 21).D.J. HANAHAN, C.A. DEMOPOULOS, J. LIEHR and R.N. PINCKARD: Identification of PF isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine. J.Biol.Chem. 25: 5514 (1980).Google Scholar